VectivBio Holding AG. (4/8/21). "Press Release: VectivBio Announces Pricing of Initial Public Offering". Basel. |
2021-04-08 |
Artios Pharma Ltd.. (4/7/21). "Press Release: Artios Pharma Announces Collaboration with Novartis to Create Next Generation DDR Cancer Therapies". Cambridge & New York, NY. |
2021-04-07 |
Delta 4 GmbH. (4/7/21). "Press Release: Delta 4 Announces Closing of Multi-million Series A Financing Round". Vienna. |
2021-04-07 |
Metagenomi Inc.. (4/7/21). "Press Release: Metagenomi Extends Series A Financing from RA Capital and Welcomes Andrew Levin to Its Board of Directors". Emeryville, CA. |
2021-04-07 |
Metagenomi Inc.. (4/7/21). "Press Release: Metagenomi Announces the Addition of Leading Immuno-oncology Clinical Research Experts to Its Scientific Advisory Board". Emeryville, CA. |
2021-04-07 |
Immunitas Therapeutics Inc.. (4/7/21). "Press Release: Lonza and Immunitas Therapeutics Announce Manufacturing Agreement to Rapidly Advance Lead Program to the Clinic". Basel. |
2021-04-07 |
Oxford Biomedica plc. (5/6/21). "Press Release: Oxford Biomedica Signs a New Three Year Development & Supply Agreement with Boehringer Ingelheim for the Manufacture and Supply of Viral Vectors". Oxford. |
2021-04-06 |
ADC Therapeutics S.A.. (4/6/21). "Press Release: Overland ADCT BioPharma Appoints Eric Koo as Chief Executive Officer". Boston, MA, Shanghai & Lausanne. |
2021-04-06 |
Valneva S.E.. (4/6/21). "Press Release: Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001". Saint-Herblain. |
2021-04-06 |
Drägerwerk AG & Co. KGaA. (4/1/21). "Press Release: Dräger Acquires Majority Share of Swiss Medical Technology Start-up STIMIT". Lübeck. |
2021-04-01 |
Promega Corporation. (4/1/21). "Press Release: New General Manager at Promega GmbH. Hans-Joachim Müller Takes Over Business from April 1, 2021". Walldorf. |
2021-04-01 |
Curexsys GmbH. (4/1/21). "Press Release: Michael Shalmi Joins Curexsys’ Board of Directors as Chairman of the Supervisory Board". Göttingen. |
2021-04-01 |
Traceless Materials GmbH. (4/21). "Press Release: Seed Financing Round for Female-founded Circular Bioeconomy Startup Traceless Materials". Hamburg. |
2021-04-01 |
Immunic, Inc.. (3/31/21). "Press Release: Immunic and 4SC AG Sign Agreement Regarding the Settlement of Royalty Obligations for Immunic’s Lead Program, IMU-838". New York, NY & Planegg-Martinsried. |
2021-03-31 |
Rentschler Biopharma SE. (3/31/21). "Press Release: Rentschler Biopharma Appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation". Laupheim & Milford, MA. |
2021-03-31 |
Knauer Wissenschaftliche Geräte GmbH. (3/31/21). "Press Release: Carsten Losch Joins General Management at Knauer". |
2021-03-31 |
OncoResponse, Inc.. (3/31/21). "Press Release: OncoResponse Raises $40.6 Million Series C Financing". Seattle, WA. |
2021-03-31 |
Pyxis Oncology, Inc.. (3/30/21). "Press Release: Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics". Cambridge, MA. |
2021-03-30 |
Inbrain Neuroelectronics S.L.. (3/26/21). "Press Release: Inbrain Neuroelectronics Raises Over €14M Series A". Barcelona. |
2021-03-26 |
Immuneering Corporation. (3/25/21). "Press Release: Immuneering Expands Leadership Team with Appointment of Carolina Garcia Rizo, Ph.D., MBA, as Chief Business Officer". Cambridge, MA. |
2021-03-25 |
Allcyte GmbH. (3/25/21). "Press Release: Austrian Biotech Allcyte Raises $6m Seed Round Following Breakthrough Cancer Clinical Trial". |
2021-03-25 |
ProBioGen AG. (3/24/21). "Press Release: ProBioGen Enters into Agreement with Nobelpharma for Manufacturing Process Development of their Vaccine Project". Berlin. |
2021-03-24 |
Cytosurge AG. (3/24/21). "Press Release: Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeks". Zürich. |
2021-03-24 |
Evolva S.A.. (3/24/21). "Press Release: Evolva Announces New Chief Financial Officer". Reinach. |
2021-03-24 |
Leukocare AG. (3/24/21). "Press Release: Leukocare and Formycon Cooperate in the Development of High-quality Biopharmaceuticals". Martinsried. |
2021-03-24 |
Numares AG. (3/24/21). "Press Release: Numares Announces FDA 510(k) Submission of Axinon System, a NMR Platform for Metabolomics-based, AI-driven Diagnostics". Boston, MA & Regensburg. |
2021-03-24 |
Dunad Therapeutics. (3/23/21). "Press Release: Dunad Therapeutics Emerges to Develop Next-generation Small Molecule Therapeutics Based on First Tuneable Targeted Protein Degradation Technology". Cambridge. |
2021-03-23 |
Relief Therapeutics Holding AG. (3/22/21). "Press Release: Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine D |
2021-03-22 |
Rentschler Biopharma SE. (3/22/21). "Press Release: Rentschler Biopharma and Leukocare Extend Service Offering with Joint U.S. Site". Geneva & Newton, MA. |
2021-03-22 |
Evotec SE. (3/22/21). "Press Release: Evotec and Takeda Enter Strategic RNA Targeting Drug Discovery and Development Alliance". Hamburg. |
2021-03-22 |
Novartis AG. (3/22/21). "Press Release: Novartis Appoints Karen Hale as Chief Legal Officer". Basel. |
2021-03-22 |
Indivumed GmbH. (3/18/21). "Press Release: Indivumed Announces Expansion into Drug Development, Formation of Ix Therapeutics. Joint Venture with Xlife Sciences". Hamburg. |
2021-03-18 |
Selexis S.A.. (3/18/21). "Press Release: SpyBiotech Licenses Selexis Best-in-Class Cell Line Development Technologies to Advance Human Cytomegalovirus VLP Vaccine Program". Geneva. |
2021-03-18 |
Life Sciences Partners (LSP). (3/18/21). "Press Release: LSP Announces Closing of Upsized $120 Million Nasdaq IPO of European Biotech Acquisition Corp (EBAC) Targeting European Biotech". Amsterdam. |
2021-03-18 |
Bruker Corporation. (3/18/21). "Press Release: Acuity Spatial Genomics Announces Formation to Open up New Frontiers for in situ, Spatial 3D Genomics". San José, CA & Boston, MA. |
2021-03-18 |
Aktis Oncology. (3/18/21). "Press Release: Aktis Oncology Announces $72m Series A Financing to Advance Breakthrought Radiopharmaceuticals to Treat Solid Tumors". Cambridge, MA. |
2021-03-18 |
Scienion AG. (3/18/21). "Press Release: Gilupi and Scienion Announce Collaboration for the Development of Single-Cell CTC Analysis". Potsdam & Berlin. |
2021-03-18 |
Nordic Nanovector ASA. (3/18/21). "Press Release: Nordic Nanovector Appoints Experienced Pharmaceutical Company Leader Peter L. Braun as Chief Executive Officer". Potsdam & Berlin. |
2021-03-18 |
Amphista Therapeutics Ltd.. (3/17/21). "Press Release: Amphista Therapeutics Raises $53M in Oversubscribed Series B Round to Advance Next Generation Targeted Protein Degradation Assets". Glasgow. |
2021-03-17 |
Inflammatix, Inc.. (3/16/21). "Press Release: Inflammatix Secures $102 Million in Series D Financing Led by D1 Capital Partners to Commercialize Novel Host Response Diagnostics". Burlingame, CA. |
2021-03-16 |
Leica Microsystems AG. (3/16/21). "Press Release: Leica Microsystems Acquires Aivia, a Leading AI-enabled 3D Microscopy, Image Visualization and Analysis Software Solution". Wetzlar. |
2021-03-16 |
Roche. (3/15/21). "Press Release: Roche Signs Definitive Merger Agreement with GenMark Diagnostics, Inc., to Access Novel Technology to Test for Broad Range of Pathogens with One Patient Sample". Basel. |
2021-03-15 |
Antiverse Ltd.. (3/15/21). "Press Release: Antiverse Raises £1.4 Million ($2 Million USD) to Advance Its AI Antibody Drug Discovery Platform". |
2021-03-15 |
Relief Therapeutics Holding AG. (3/12/21). "Press Release: Relief Announces CHF 10 Million Private Placement". Geneva. |
2021-03-12 |
Monte Rosa Therapeutics. (3/12/21). "Press Release: Monte Rosa Therapeutics Announces $95 Million Series C Financing to Accelerate Next-generation Protein Degradation Platform". Boston, MA. |
2021-03-12 |
InfanDx AG. (3/11/21). "Press Release: Neonatal Diagnostics Company InfanDx Closes Interim Financing Round". Cologne. |
2021-03-11 |
Touchlight Genetics Ltd.. (3/11/21). "Press Release: Touchlight Raises £42 Million ($58 Million) to Meet Unprecedented Global DNA Demand". Hampton. |
2021-03-11 |
Agomab Therapeutics N.V.. (3/10/21). "Press Release: AgomAb Therapeutics Raises $74 Million Series B to Advance Regenerative Pathway Modulators". Ghent. |
2021-03-10 |
BellaSeno GmbH. (3/10/21). "Press Release: BellaSeno and Fraunhofer Institute for Production Technology IPT Receive EUR 1.4 Million BMBF Grant". Leipzig & Aachen. |
2021-03-10 |
KWS Saat SE & Co. KGaA. (3/10/21). "Press Release: KWS Acquires Tomato Breeding Company". Einbeck & Wageningen. |
2021-03-10 |
BioPhero ApS. (3/9/21). "Press Release: BioPhero Announces $17 Million Series A For Sustainable Pest Control". Copenhagen. |
2021-03-09 |
Visus Therapeutics Inc.. (3/9/21). "Press Release: Visus Therapeutics Announces $36 Million Series A Financing to Advance Development of Novel Presbyopia-correcting Eye Drop". Seattle, WA. |
2021-03-09 |
NeoPhore Ltd.. (3/9/21). "Press Release: NeoPhore Announces £15.2m Financing to Advance DNA Mismatch Repair Pipeline". Cambridge. |
2021-03-09 |
Mikrogen GmbH. (3/8/21). "Press Release: Mikrogen Acquires Lophius Biosciences to Expand into T Cell-Based Testing Market". Neuried & Regensburg. |
2021-03-08 |
Autifony Therapeutics Ltd.. (3/4/21). "Press Release: Autifony Therapeutics, Boehringer Ingelheim to Collaborate On Novel Ion Channel Target with Potential in Multiple Disease Areas Related to Lysosomal Storage Disorders". Stevenage. |
2021-03-04 |
Biognosys AG. (3/4/21). "Press Release: Biognosys Announces Development Roadmap for Large-Scale Discovery Proteomics in Plasma". Schlieren. |
2021-03-04 |
Bicoll GmbH. (3/4/21). "Press Release: Taste Active Small Molecules in Plants Identified by Data Mining of Historical Manuscripts from China". Planegg-Martinsried. |
2021-03-04 |
Sofinnova Partners. (3/3/21). "Press Release: Sofinnova Partners Closes €445M ($540M) Oversubscribed Late-stage Healthcare Crossover Fund". Paris. |
2021-03-03 |
Atai Life Sciences AG. (3/3/21). "Press Release: Atai Life Sciences Announces the Closing of Its $157 Million Series D Financing Round". New York, NY. |
2021-03-03 |
Argobio SAS. (3/2/21). "Press Release: Argobio Announces Its Launch with 50 M€ to Create and Develop Pioneering Biotech Spinouts with the Support of Bpifrance, Kurma Partners, Angelini Pharma, Evotec, and the Institut Pasteur". Paris. |
2021-03-02 |
Molecular Health GmbH. (3/2/21). "Press Release: Molecular Health and Falco Biosystems Team Up to Provide Genetic Analysis Services Using MH Guide/BRCA and MH Guide/Mendel". Heidelberg. |
2021-03-02 |
ActiTrexx GmbH. (3/2/21). "Press Release: Newly Founded Biotech Company ActiTrexx Receives Funding of € 3.5 Million to Develop Cell Therapy against Transplant Rejection". Mainz. |
2021-03-02 |
eGenesis Inc.. (3/2/21). "Press Release: eGenesis Announces $125 Million Series C Financing". Cambridge, MA. |
2021-03-02 |
Chemieanlagenbau Chemnitz GmbH. (3/1/21). "Press Release: CAC Builds Biofuel Plant for OMV in Schwechat (A)". Chemnitz. |
2021-03-01 |
Leukocare AG. (3/1/21). "Press Release: Leukocare and Malvern Collaborate on Stabilization and Formulation Development of COVID-19 Vaccines". Martinsried & Malvern. |
2021-03-01 |
FogPharma (Fog Pharmaceuticals Inc.). (3/1/21). "Press Release: FogPharma Announces $107 Million Series C Financing to Advance Direct ß-Catenin Antagonist and Universal Druggability Platform". Cambridge, MA. |
2021-03-01 |
Sarcura GmbH. (3/21). "Press Release: Sarcura Received a 1.5 m € Research Grant from FFG". |
2021-03-01 |
Merck KGaA. (3/1/21). "Press Release: Merck Builds on Leadership in Head and Neck Cancer Through Worldwide Licensing Agreement with Debiopharm for Pivotal-Stage Xevinapant". Darmstadt. |
2021-03-01 |
Nabriva Therapeutics plc. (2/26/21). "Press Release: Nabriva Therapeutics Appoints Daniel Dolan as Chief Financial Officer". Dublin & King of Prussia, PA. |
2021-02-26 |
Roivant Sciences GmbH. (2/26/21). "Press Release: Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics". New York, NY, Boston, MA & Basel. |
2021-02-26 |
Immunic, Inc.. (2/26/21). "Press Release: Immunic, Inc. Reports Year End 2020 Financial Results and Highlights Recent Activity". New York, NY. |
2021-02-26 |
Bruker Corporation. (2/25/21). "Press Release: New Nature Communications Publication by Mann & Theis Groups Harnesses the Benefits of Large-scale Peptide Collisional Cross Section (CCS) Measurements and Deep Learning for 4D Proteomics". Munich. |
2021-02-25 |
Coulter Partners. (2/25/21). "Press Release: Coulter Partners Announces New Appointments in London, the US and Germany". |
2021-02-25 |
Celonic AG. (2/25/21). "Press Release: Celonic to Boost its Cell & Gene Therapy Production with Facility in the Upcoming Life Science Park Rheintal in Stein, Switzerland". Basel. |
2021-02-25 |
Vividion Therapeutics, Inc.. (2/24/21). "Press Release: Vividion Announces $135 Million Series C Financing to Fuel Broad Pipeline of Precision Oncology and Immunology Programs". San Diego, CA. |
2021-02-24 |
10x Genomics, Inc.. (2/24/21). "Press Release: 10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event. Acquires Tetramer Shop, Reveals Details on Upcoming Products". Pleasanton, CA. |
2021-02-24 |
Enamine Ltd.. (2/24/21). "Press Release: Enamine Extend Collaboration with Prominent Swiss Biotech". Kyiv. |
2021-02-24 |
Orna Therapeutics, Inc.. (2/24/21). "Press Release: Orna Therapeutics Launches with over $100M Raised to Develop a New Class of Fully Engineered Circular RNA Therapies". Cambridge, MA. |
2021-02-24 |
Bruker Corporation. (2/22/21). "Press Release: Bruker Corporation to Present at Investor Conferences". Billerica, MA. |
2021-02-22 |
Resolve Biosciences GmbH. (2/22/21). "Press Release: Resolve Biosciences Announces Initial Results from Early Access Collaborations with Scientists Leading the Next Generation of Subcellular Spatial Analysis". Monheim am Rhein. |
2021-02-22 |
Minaris Regnerative Medicine GmbH. (2/22/21). "Press Release: MaxiVAX and Minaris Regenerative Medicine Enter into a Manufacturing Partnership for MVX-ONCO-2 Cancer Immunotherapy". Geneva & Munich. |
2021-02-22 |
Bruker Corporation. (2/18/21). "Press Release: Bruker Announces Quarterly Dividend". Billerica, MA. |
2021-02-18 |
Humacyte, Inc.. (2/17/21). "Press Release: Humacyte, a Transformative Biotechnology Platform Company Capable of Manufacturing Universally Implantable Bioengineered Human Tissue at Commercial Scale, Going Public via Merger with Alpha Healthcare Acquisitio |
2021-02-17 |
ERS Genomics Ltd.. (2/16/21). "Press Release: ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement". Dublin & Barcelona. |
2021-02-16 |
Biomunex Pharmaceuticals SASU. (2/16/21). "Press Release: Biomunex Pharmaceuticals Signs Strategic License and Co-Development Agreement with Onward Therapeutics for Proprietary Bispecific Antibody Program". Paris & Cambridge, MA. |
2021-02-16 |
Hygiena, LLC. (2/16/21). "Press Release: EW Group Announces the Acquisition of Hygiena from Warburg Pincus to Form a Leading Food Safety, Veterinary and Environmental Diagnostic Solutions Company". Visbek & Camarillo, CA. |
2021-02-16 |
Bruker Corporation. (2/16/21). "Press Release: Bruker Reports Fourth Quarter and Fiscal Year 2020 Financial Results". Billerica, MA. |
2021-02-16 |
Cellink AB. (2/15/21). "Press Release: Cellink Has Entered into an Agreement to Acquire the Advanced Robotics and Diagnostics Automation Company Ginolis". |
2021-02-15 |
CureVac N.V.. (2/12/21). "Press Release: CureVac Initiates Rolling Submission with European Medicines Agency for COVID-19 Vaccine Candidate, CVnCoV". Tübingen & Boston, MA. |
2021-02-12 |
Priavoid GmbH. (2/12/21). "Press Release: Priavoid Closes Financing Round". Düsseldorf. |
2021-02-12 |
Sophia Genetics S.A.. (2/11/21). "Press Release: Sophia Genetics Appoints Ross Muken as Chief Financial Officer". Boston, MA & Lausanne. |
2021-02-11 |
Novartis AG. (2/11/21). "Press Release: Sandoz Announces Agreement to Acquire GSK’s Cephalosporin Antibiotics Business, Reinforcing Its Leading Global Position in Antibiotics". Basel. |
2021-02-11 |
Evonik Industries AG. (2/11/21). "Press Release: Evonik Strengthens Strategic Partnership with BioNTech on COVID-19 Vaccine". Essen. |
2021-02-11 |
Rentschler Biopharma SE. (2/11/21). "Press Release: Rentschler Biopharma Establishes Center of Excellence for Cell and Gene Therapy in the UK". Laupheim & Stevenage. |
2021-02-11 |
Rentschler Biopharma SE. (2/11/21). "Press Release: Rentschler Biopharma to Build New Cell and Gene Therapy Capabilities in the UK". London & Laupheim. |
2021-02-11 |
Quell Therapeutics Ltd.. (2/11/21). "Press Release: Quell Therapeutics Expands Series A Financing to $84 Million". London. |
2021-02-11 |
Forbion Capital Partners. (2/10/21). "Press Release: Launch of Novel Gene Therapy Company, VectorY, to Develop Innovative Vectorized Antibodies". Amsterdam. |
2021-02-10 |
MedLumics. (2/10/21). "Press Release: MedLumics Closes Upsized EUR 18M (21.7M USD) Financing Round and Appoints New Chairman". Madrid. |
2021-02-10 |
Labster ApS. (2/10/21). "Press Release: Labster Secures $60M in Series C Funding Led by Andreessen Horowitz". Boston, MA. |
2021-02-10 |
Evotec SE. (2/9/21). "Press Release: Evotec and Related Sciences Enter Integrated Drug Discovery and Development Partnership". Hamburg. |
2021-02-09 |